Global Human Microbiome Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Human Microbiome market size is predicted to grow from US$ 556 million in 2025 to US$ 1880 million in 2031; it is expected to grow at a CAGR of 22.5% from 2025 to 2031.
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
LPI (LP Information)' newest research report, the “Human Microbiome Industry Forecast” looks at past sales and reviews total world Human Microbiome sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Microbiome sales for 2025 through 2031. With Human Microbiome sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Microbiome industry.
This Insight Report provides a comprehensive analysis of the global Human Microbiome landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Microbiome portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Microbiome market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Microbiome and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Microbiome.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Human Microbiome market size is predicted to grow from US$ 556 million in 2025 to US$ 1880 million in 2031; it is expected to grow at a CAGR of 22.5% from 2025 to 2031.
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
LPI (LP Information)' newest research report, the “Human Microbiome Industry Forecast” looks at past sales and reviews total world Human Microbiome sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Microbiome sales for 2025 through 2031. With Human Microbiome sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Microbiome industry.
This Insight Report provides a comprehensive analysis of the global Human Microbiome landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Microbiome portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Microbiome market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Microbiome and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Microbiome.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Gastrointestinal Tract Human Micobiome
- Urogenital Tract Human Micobiome
- Others
- Treatment
- Diagnosis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Vedanta
- Seres Therapeutics
- Second Genome
- Rebiotix
- ActoGeniX
- Enterome BioScience
- AvidBiotics
- 4D Pharma Research Ltd
- Enterologics
- Metabogen
- Metabiomics
- Ritter Pharmaceuticals
- Osel
- Symberix
- Miomics
- Symbiotix Biotherapies
- MicroBiome Therapeutics LLC
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Microbiome Market Size (2020-2031)
2.1.2 Human Microbiome Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Human Microbiome by Country/Region (2020, 2024 & 2031)
2.2 Human Microbiome Segment by Type
2.2.1 Gastrointestinal Tract Human Micobiome
2.2.2 Urogenital Tract Human Micobiome
2.2.3 Others
2.3 Human Microbiome Market Size by Type
2.3.1 Human Microbiome Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Human Microbiome Market Size Market Share by Type (2020-2025)
2.4 Human Microbiome Segment by Application
2.4.1 Treatment
2.4.2 Diagnosis
2.5 Human Microbiome Market Size by Application
2.5.1 Human Microbiome Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Human Microbiome Market Size Market Share by Application (2020-2025)
3 HUMAN MICROBIOME MARKET SIZE BY PLAYER
3.1 Human Microbiome Market Size Market Share by Player
3.1.1 Global Human Microbiome Revenue by Player (2020-2025)
3.1.2 Global Human Microbiome Revenue Market Share by Player (2020-2025)
3.2 Global Human Microbiome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN MICROBIOME BY REGION
4.1 Human Microbiome Market Size by Region (2020-2025)
4.2 Global Human Microbiome Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Microbiome Market Size Growth (2020-2025)
4.4 APAC Human Microbiome Market Size Growth (2020-2025)
4.5 Europe Human Microbiome Market Size Growth (2020-2025)
4.6 Middle East & Africa Human Microbiome Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Human Microbiome Market Size by Country (2020-2025)
5.2 Americas Human Microbiome Market Size by Type (2020-2025)
5.3 Americas Human Microbiome Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Microbiome Market Size by Region (2020-2025)
6.2 APAC Human Microbiome Market Size by Type (2020-2025)
6.3 APAC Human Microbiome Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Microbiome Market Size by Country (2020-2025)
7.2 Europe Human Microbiome Market Size by Type (2020-2025)
7.3 Europe Human Microbiome Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Microbiome by Region (2020-2025)
8.2 Middle East & Africa Human Microbiome Market Size by Type (2020-2025)
8.3 Middle East & Africa Human Microbiome Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN MICROBIOME MARKET FORECAST
10.1 Global Human Microbiome Forecast by Region (2026-2031)
10.1.1 Global Human Microbiome Forecast by Region (2026-2031)
10.1.2 Americas Human Microbiome Forecast
10.1.3 APAC Human Microbiome Forecast
10.1.4 Europe Human Microbiome Forecast
10.1.5 Middle East & Africa Human Microbiome Forecast
10.2 Americas Human Microbiome Forecast by Country (2026-2031)
10.2.1 United States Market Human Microbiome Forecast
10.2.2 Canada Market Human Microbiome Forecast
10.2.3 Mexico Market Human Microbiome Forecast
10.2.4 Brazil Market Human Microbiome Forecast
10.3 APAC Human Microbiome Forecast by Region (2026-2031)
10.3.1 China Human Microbiome Market Forecast
10.3.2 Japan Market Human Microbiome Forecast
10.3.3 Korea Market Human Microbiome Forecast
10.3.4 Southeast Asia Market Human Microbiome Forecast
10.3.5 India Market Human Microbiome Forecast
10.3.6 Australia Market Human Microbiome Forecast
10.4 Europe Human Microbiome Forecast by Country (2026-2031)
10.4.1 Germany Market Human Microbiome Forecast
10.4.2 France Market Human Microbiome Forecast
10.4.3 UK Market Human Microbiome Forecast
10.4.4 Italy Market Human Microbiome Forecast
10.4.5 Russia Market Human Microbiome Forecast
10.5 Middle East & Africa Human Microbiome Forecast by Region (2026-2031)
10.5.1 Egypt Market Human Microbiome Forecast
10.5.2 South Africa Market Human Microbiome Forecast
10.5.3 Israel Market Human Microbiome Forecast
10.5.4 Turkey Market Human Microbiome Forecast
10.6 Global Human Microbiome Forecast by Type (2026-2031)
10.7 Global Human Microbiome Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Human Microbiome Forecast
11 KEY PLAYERS ANALYSIS
11.1 Vedanta
11.1.1 Vedanta Company Information
11.1.2 Vedanta Human Microbiome Product Offered
11.1.3 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Vedanta Main Business Overview
11.1.5 Vedanta Latest Developments
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Information
11.2.2 Seres Therapeutics Human Microbiome Product Offered
11.2.3 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Seres Therapeutics Main Business Overview
11.2.5 Seres Therapeutics Latest Developments
11.3 Second Genome
11.3.1 Second Genome Company Information
11.3.2 Second Genome Human Microbiome Product Offered
11.3.3 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Second Genome Main Business Overview
11.3.5 Second Genome Latest Developments
11.4 Rebiotix
11.4.1 Rebiotix Company Information
11.4.2 Rebiotix Human Microbiome Product Offered
11.4.3 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Rebiotix Main Business Overview
11.4.5 Rebiotix Latest Developments
11.5 ActoGeniX
11.5.1 ActoGeniX Company Information
11.5.2 ActoGeniX Human Microbiome Product Offered
11.5.3 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 ActoGeniX Main Business Overview
11.5.5 ActoGeniX Latest Developments
11.6 Enterome BioScience
11.6.1 Enterome BioScience Company Information
11.6.2 Enterome BioScience Human Microbiome Product Offered
11.6.3 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Enterome BioScience Main Business Overview
11.6.5 Enterome BioScience Latest Developments
11.7 AvidBiotics
11.7.1 AvidBiotics Company Information
11.7.2 AvidBiotics Human Microbiome Product Offered
11.7.3 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 AvidBiotics Main Business Overview
11.7.5 AvidBiotics Latest Developments
11.8 4D Pharma Research Ltd
11.8.1 4D Pharma Research Ltd Company Information
11.8.2 4D Pharma Research Ltd Human Microbiome Product Offered
11.8.3 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 4D Pharma Research Ltd Main Business Overview
11.8.5 4D Pharma Research Ltd Latest Developments
11.9 Enterologics
11.9.1 Enterologics Company Information
11.9.2 Enterologics Human Microbiome Product Offered
11.9.3 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Enterologics Main Business Overview
11.9.5 Enterologics Latest Developments
11.10 Metabogen
11.10.1 Metabogen Company Information
11.10.2 Metabogen Human Microbiome Product Offered
11.10.3 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Metabogen Main Business Overview
11.10.5 Metabogen Latest Developments
11.11 Metabiomics
11.11.1 Metabiomics Company Information
11.11.2 Metabiomics Human Microbiome Product Offered
11.11.3 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Metabiomics Main Business Overview
11.11.5 Metabiomics Latest Developments
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Information
11.12.2 Ritter Pharmaceuticals Human Microbiome Product Offered
11.12.3 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Ritter Pharmaceuticals Main Business Overview
11.12.5 Ritter Pharmaceuticals Latest Developments
11.13 Osel
11.13.1 Osel Company Information
11.13.2 Osel Human Microbiome Product Offered
11.13.3 Osel Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Osel Main Business Overview
11.13.5 Osel Latest Developments
11.14 Symberix
11.14.1 Symberix Company Information
11.14.2 Symberix Human Microbiome Product Offered
11.14.3 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Symberix Main Business Overview
11.14.5 Symberix Latest Developments
11.15 Miomics
11.15.1 Miomics Company Information
11.15.2 Miomics Human Microbiome Product Offered
11.15.3 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Miomics Main Business Overview
11.15.5 Miomics Latest Developments
11.16 Symbiotix Biotherapies
11.16.1 Symbiotix Biotherapies Company Information
11.16.2 Symbiotix Biotherapies Human Microbiome Product Offered
11.16.3 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Symbiotix Biotherapies Main Business Overview
11.16.5 Symbiotix Biotherapies Latest Developments
11.17 MicroBiome Therapeutics LLC
11.17.1 MicroBiome Therapeutics LLC Company Information
11.17.2 MicroBiome Therapeutics LLC Human Microbiome Product Offered
11.17.3 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 MicroBiome Therapeutics LLC Main Business Overview
11.17.5 MicroBiome Therapeutics LLC Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Human Microbiome Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Human Microbiome Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of GastrointestinalTract Human Micobiome
Table 4. Major Players of UrogenitalTract Human Micobiome
Table 5. Major Players of Others
Table 6. Human Microbiome Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 8. Global Human Microbiome Market Size Market Share byType (2020-2025)
Table 9. Human Microbiome Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Human Microbiome Market Size Market Share by Application (2020-2025)
Table 12. Global Human Microbiome Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Human Microbiome Revenue Market Share by Player (2020-2025)
Table 14. Human Microbiome Key Players Head office and Products Offered
Table 15. Human Microbiome Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Human Microbiome Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Human Microbiome Market Size Market Share by Region (2020-2025)
Table 20. Global Human Microbiome Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Human Microbiome Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Human Microbiome Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Human Microbiome Market Size Market Share by Country (2020-2025)
Table 24. Americas Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Human Microbiome Market Size Market Share byType (2020-2025)
Table 26. Americas Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Human Microbiome Market Size Market Share by Application (2020-2025)
Table 28. APAC Human Microbiome Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Human Microbiome Market Size Market Share by Region (2020-2025)
Table 30. APAC Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Human Microbiome Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Human Microbiome Market Size Market Share by Country (2020-2025)
Table 34. Europe Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Human Microbiome Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Human Microbiome
Table 40. Key Market Challenges & Risks of Human Microbiome
Table 41. Key IndustryTrends of Human Microbiome
Table 42. Global Human Microbiome Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Human Microbiome Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Human Microbiome Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Human Microbiome Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Vedanta Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 47. Vedanta Human Microbiome Product Offered
Table 48. Vedanta Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Vedanta Main Business
Table 50. Vedanta Latest Developments
Table 51. SeresTherapeutics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 52. SeresTherapeutics Human Microbiome Product Offered
Table 53. SeresTherapeutics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. SeresTherapeutics Main Business
Table 55. SeresTherapeutics Latest Developments
Table 56. Second Genome Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 57. Second Genome Human Microbiome Product Offered
Table 58. Second Genome Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Second Genome Main Business
Table 60. Second Genome Latest Developments
Table 61. Rebiotix Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 62. Rebiotix Human Microbiome Product Offered
Table 63. Rebiotix Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Rebiotix Main Business
Table 65. Rebiotix Latest Developments
Table 66. ActoGeniX Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 67. ActoGeniX Human Microbiome Product Offered
Table 68. ActoGeniX Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. ActoGeniX Main Business
Table 70. ActoGeniX Latest Developments
Table 71. Enterome BioScience Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 72. Enterome BioScience Human Microbiome Product Offered
Table 73. Enterome BioScience Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Enterome BioScience Main Business
Table 75. Enterome BioScience Latest Developments
Table 76. AvidBiotics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 77. AvidBiotics Human Microbiome Product Offered
Table 78. AvidBiotics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. AvidBiotics Main Business
Table 80. AvidBiotics Latest Developments
Table 81. 4D Pharma Research Ltd Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 82. 4D Pharma Research Ltd Human Microbiome Product Offered
Table 83. 4D Pharma Research Ltd Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. 4D Pharma Research Ltd Main Business
Table 85. 4D Pharma Research Ltd Latest Developments
Table 86. Enterologics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 87. Enterologics Human Microbiome Product Offered
Table 88. Enterologics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Enterologics Main Business
Table 90. Enterologics Latest Developments
Table 91. Metabogen Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 92. Metabogen Human Microbiome Product Offered
Table 93. Metabogen Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Metabogen Main Business
Table 95. Metabogen Latest Developments
Table 96. Metabiomics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 97. Metabiomics Human Microbiome Product Offered
Table 98. Metabiomics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Metabiomics Main Business
Table 100. Metabiomics Latest Developments
Table 101. Ritter Pharmaceuticals Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 102. Ritter Pharmaceuticals Human Microbiome Product Offered
Table 103. Ritter Pharmaceuticals Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Ritter Pharmaceuticals Main Business
Table 105. Ritter Pharmaceuticals Latest Developments
Table 106. Osel Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 107. Osel Human Microbiome Product Offered
Table 108. Osel Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Osel Main Business
Table 110. Osel Latest Developments
Table 111. Symberix Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 112. Symberix Human Microbiome Product Offered
Table 113. Symberix Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Symberix Main Business
Table 115. Symberix Latest Developments
Table 116. Miomics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 117. Miomics Human Microbiome Product Offered
Table 118. Miomics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Miomics Main Business
Table 120. Miomics Latest Developments
Table 121. Symbiotix Biotherapies Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 122. Symbiotix Biotherapies Human Microbiome Product Offered
Table 123. Symbiotix Biotherapies Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Symbiotix Biotherapies Main Business
Table 125. Symbiotix Biotherapies Latest Developments
Table 126. MicroBiomeTherapeutics LLC Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 127. MicroBiomeTherapeutics LLC Human Microbiome Product Offered
Table 128. MicroBiomeTherapeutics LLC Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. MicroBiomeTherapeutics LLC Main Business
Table 130. MicroBiomeTherapeutics LLC Latest Developments
LIST OFFIGURES
Figure 1. Human Microbiome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Microbiome Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Human Microbiome Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Human Microbiome Sales Market Share by Country/Region (2024)
Figure 8. Human Microbiome Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Human Microbiome Market Size Market Share byType in 2024
Figure 10. Human Microbiome inTreatment
Figure 11. Global Human Microbiome Market:Treatment (2020-2025) & ($ millions)
Figure 12. Human Microbiome in Diagnosis
Figure 13. Global Human Microbiome Market: Diagnosis (2020-2025) & ($ millions)
Figure 14. Global Human Microbiome Market Size Market Share by Application in 2024
Figure 15. Global Human Microbiome Revenue Market Share by Player in 2024
Figure 16. Global Human Microbiome Market Size Market Share by Region (2020-2025)
Figure 17. Americas Human Microbiome Market Size 2020-2025 ($ millions)
Figure 18. APAC Human Microbiome Market Size 2020-2025 ($ millions)
Figure 19. Europe Human Microbiome Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Human Microbiome Market Size 2020-2025 ($ millions)
Figure 21. Americas Human Microbiome Value Market Share by Country in 2024
Figure 22. United States Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Human Microbiome Market Size Market Share by Region in 2024
Figure 27. APAC Human Microbiome Market Size Market Share byType (2020-2025)
Figure 28. APAC Human Microbiome Market Size Market Share by Application (2020-2025)
Figure 29. China Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 33. India Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Human Microbiome Market Size Market Share by Country in 2024
Figure 36. Europe Human Microbiome Market Size Market Share byType (2020-2025)
Figure 37. Europe Human Microbiome Market Size Market Share by Application (2020-2025)
Figure 38. Germany Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 39.France Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Human Microbiome Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Human Microbiome Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Human Microbiome Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Human Microbiome Market Size 2026-2031 ($ millions)
Figure 52. APAC Human Microbiome Market Size 2026-2031 ($ millions)
Figure 53. Europe Human Microbiome Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Human Microbiome Market Size 2026-2031 ($ millions)
Figure 55. United States Human Microbiome Market Size 2026-2031 ($ millions)
Figure 56. Canada Human Microbiome Market Size 2026-2031 ($ millions)
Figure 57. Mexico Human Microbiome Market Size 2026-2031 ($ millions)
Figure 58. Brazil Human Microbiome Market Size 2026-2031 ($ millions)
Figure 59. China Human Microbiome Market Size 2026-2031 ($ millions)
Figure 60. Japan Human Microbiome Market Size 2026-2031 ($ millions)
Figure 61. Korea Human Microbiome Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Human Microbiome Market Size 2026-2031 ($ millions)
Figure 63. India Human Microbiome Market Size 2026-2031 ($ millions)
Figure 64. Australia Human Microbiome Market Size 2026-2031 ($ millions)
Figure 65. Germany Human Microbiome Market Size 2026-2031 ($ millions)
Figure 66.France Human Microbiome Market Size 2026-2031 ($ millions)
Figure 67. UK Human Microbiome Market Size 2026-2031 ($ millions)
Figure 68. Italy Human Microbiome Market Size 2026-2031 ($ millions)
Figure 69. Russia Human Microbiome Market Size 2026-2031 ($ millions)
Figure 70. Egypt Human Microbiome Market Size 2026-2031 ($ millions)
Figure 71. South Africa Human Microbiome Market Size 2026-2031 ($ millions)
Figure 72. Israel Human Microbiome Market Size 2026-2031 ($ millions)
Figure 73.Turkey Human Microbiome Market Size 2026-2031 ($ millions)
Figure 74. Global Human Microbiome Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Human Microbiome Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Human Microbiome Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Microbiome Market Size (2020-2031)
2.1.2 Human Microbiome Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Human Microbiome by Country/Region (2020, 2024 & 2031)
2.2 Human Microbiome Segment by Type
2.2.1 Gastrointestinal Tract Human Micobiome
2.2.2 Urogenital Tract Human Micobiome
2.2.3 Others
2.3 Human Microbiome Market Size by Type
2.3.1 Human Microbiome Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Human Microbiome Market Size Market Share by Type (2020-2025)
2.4 Human Microbiome Segment by Application
2.4.1 Treatment
2.4.2 Diagnosis
2.5 Human Microbiome Market Size by Application
2.5.1 Human Microbiome Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Human Microbiome Market Size Market Share by Application (2020-2025)
3 HUMAN MICROBIOME MARKET SIZE BY PLAYER
3.1 Human Microbiome Market Size Market Share by Player
3.1.1 Global Human Microbiome Revenue by Player (2020-2025)
3.1.2 Global Human Microbiome Revenue Market Share by Player (2020-2025)
3.2 Global Human Microbiome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN MICROBIOME BY REGION
4.1 Human Microbiome Market Size by Region (2020-2025)
4.2 Global Human Microbiome Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Microbiome Market Size Growth (2020-2025)
4.4 APAC Human Microbiome Market Size Growth (2020-2025)
4.5 Europe Human Microbiome Market Size Growth (2020-2025)
4.6 Middle East & Africa Human Microbiome Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Human Microbiome Market Size by Country (2020-2025)
5.2 Americas Human Microbiome Market Size by Type (2020-2025)
5.3 Americas Human Microbiome Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Microbiome Market Size by Region (2020-2025)
6.2 APAC Human Microbiome Market Size by Type (2020-2025)
6.3 APAC Human Microbiome Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Microbiome Market Size by Country (2020-2025)
7.2 Europe Human Microbiome Market Size by Type (2020-2025)
7.3 Europe Human Microbiome Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Microbiome by Region (2020-2025)
8.2 Middle East & Africa Human Microbiome Market Size by Type (2020-2025)
8.3 Middle East & Africa Human Microbiome Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN MICROBIOME MARKET FORECAST
10.1 Global Human Microbiome Forecast by Region (2026-2031)
10.1.1 Global Human Microbiome Forecast by Region (2026-2031)
10.1.2 Americas Human Microbiome Forecast
10.1.3 APAC Human Microbiome Forecast
10.1.4 Europe Human Microbiome Forecast
10.1.5 Middle East & Africa Human Microbiome Forecast
10.2 Americas Human Microbiome Forecast by Country (2026-2031)
10.2.1 United States Market Human Microbiome Forecast
10.2.2 Canada Market Human Microbiome Forecast
10.2.3 Mexico Market Human Microbiome Forecast
10.2.4 Brazil Market Human Microbiome Forecast
10.3 APAC Human Microbiome Forecast by Region (2026-2031)
10.3.1 China Human Microbiome Market Forecast
10.3.2 Japan Market Human Microbiome Forecast
10.3.3 Korea Market Human Microbiome Forecast
10.3.4 Southeast Asia Market Human Microbiome Forecast
10.3.5 India Market Human Microbiome Forecast
10.3.6 Australia Market Human Microbiome Forecast
10.4 Europe Human Microbiome Forecast by Country (2026-2031)
10.4.1 Germany Market Human Microbiome Forecast
10.4.2 France Market Human Microbiome Forecast
10.4.3 UK Market Human Microbiome Forecast
10.4.4 Italy Market Human Microbiome Forecast
10.4.5 Russia Market Human Microbiome Forecast
10.5 Middle East & Africa Human Microbiome Forecast by Region (2026-2031)
10.5.1 Egypt Market Human Microbiome Forecast
10.5.2 South Africa Market Human Microbiome Forecast
10.5.3 Israel Market Human Microbiome Forecast
10.5.4 Turkey Market Human Microbiome Forecast
10.6 Global Human Microbiome Forecast by Type (2026-2031)
10.7 Global Human Microbiome Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Human Microbiome Forecast
11 KEY PLAYERS ANALYSIS
11.1 Vedanta
11.1.1 Vedanta Company Information
11.1.2 Vedanta Human Microbiome Product Offered
11.1.3 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Vedanta Main Business Overview
11.1.5 Vedanta Latest Developments
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Information
11.2.2 Seres Therapeutics Human Microbiome Product Offered
11.2.3 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Seres Therapeutics Main Business Overview
11.2.5 Seres Therapeutics Latest Developments
11.3 Second Genome
11.3.1 Second Genome Company Information
11.3.2 Second Genome Human Microbiome Product Offered
11.3.3 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Second Genome Main Business Overview
11.3.5 Second Genome Latest Developments
11.4 Rebiotix
11.4.1 Rebiotix Company Information
11.4.2 Rebiotix Human Microbiome Product Offered
11.4.3 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Rebiotix Main Business Overview
11.4.5 Rebiotix Latest Developments
11.5 ActoGeniX
11.5.1 ActoGeniX Company Information
11.5.2 ActoGeniX Human Microbiome Product Offered
11.5.3 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 ActoGeniX Main Business Overview
11.5.5 ActoGeniX Latest Developments
11.6 Enterome BioScience
11.6.1 Enterome BioScience Company Information
11.6.2 Enterome BioScience Human Microbiome Product Offered
11.6.3 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Enterome BioScience Main Business Overview
11.6.5 Enterome BioScience Latest Developments
11.7 AvidBiotics
11.7.1 AvidBiotics Company Information
11.7.2 AvidBiotics Human Microbiome Product Offered
11.7.3 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 AvidBiotics Main Business Overview
11.7.5 AvidBiotics Latest Developments
11.8 4D Pharma Research Ltd
11.8.1 4D Pharma Research Ltd Company Information
11.8.2 4D Pharma Research Ltd Human Microbiome Product Offered
11.8.3 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 4D Pharma Research Ltd Main Business Overview
11.8.5 4D Pharma Research Ltd Latest Developments
11.9 Enterologics
11.9.1 Enterologics Company Information
11.9.2 Enterologics Human Microbiome Product Offered
11.9.3 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Enterologics Main Business Overview
11.9.5 Enterologics Latest Developments
11.10 Metabogen
11.10.1 Metabogen Company Information
11.10.2 Metabogen Human Microbiome Product Offered
11.10.3 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Metabogen Main Business Overview
11.10.5 Metabogen Latest Developments
11.11 Metabiomics
11.11.1 Metabiomics Company Information
11.11.2 Metabiomics Human Microbiome Product Offered
11.11.3 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Metabiomics Main Business Overview
11.11.5 Metabiomics Latest Developments
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Information
11.12.2 Ritter Pharmaceuticals Human Microbiome Product Offered
11.12.3 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Ritter Pharmaceuticals Main Business Overview
11.12.5 Ritter Pharmaceuticals Latest Developments
11.13 Osel
11.13.1 Osel Company Information
11.13.2 Osel Human Microbiome Product Offered
11.13.3 Osel Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Osel Main Business Overview
11.13.5 Osel Latest Developments
11.14 Symberix
11.14.1 Symberix Company Information
11.14.2 Symberix Human Microbiome Product Offered
11.14.3 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Symberix Main Business Overview
11.14.5 Symberix Latest Developments
11.15 Miomics
11.15.1 Miomics Company Information
11.15.2 Miomics Human Microbiome Product Offered
11.15.3 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Miomics Main Business Overview
11.15.5 Miomics Latest Developments
11.16 Symbiotix Biotherapies
11.16.1 Symbiotix Biotherapies Company Information
11.16.2 Symbiotix Biotherapies Human Microbiome Product Offered
11.16.3 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Symbiotix Biotherapies Main Business Overview
11.16.5 Symbiotix Biotherapies Latest Developments
11.17 MicroBiome Therapeutics LLC
11.17.1 MicroBiome Therapeutics LLC Company Information
11.17.2 MicroBiome Therapeutics LLC Human Microbiome Product Offered
11.17.3 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 MicroBiome Therapeutics LLC Main Business Overview
11.17.5 MicroBiome Therapeutics LLC Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Human Microbiome Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Human Microbiome Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of GastrointestinalTract Human Micobiome
Table 4. Major Players of UrogenitalTract Human Micobiome
Table 5. Major Players of Others
Table 6. Human Microbiome Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 8. Global Human Microbiome Market Size Market Share byType (2020-2025)
Table 9. Human Microbiome Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Human Microbiome Market Size Market Share by Application (2020-2025)
Table 12. Global Human Microbiome Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Human Microbiome Revenue Market Share by Player (2020-2025)
Table 14. Human Microbiome Key Players Head office and Products Offered
Table 15. Human Microbiome Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Human Microbiome Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Human Microbiome Market Size Market Share by Region (2020-2025)
Table 20. Global Human Microbiome Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Human Microbiome Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Human Microbiome Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Human Microbiome Market Size Market Share by Country (2020-2025)
Table 24. Americas Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Human Microbiome Market Size Market Share byType (2020-2025)
Table 26. Americas Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Human Microbiome Market Size Market Share by Application (2020-2025)
Table 28. APAC Human Microbiome Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Human Microbiome Market Size Market Share by Region (2020-2025)
Table 30. APAC Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Human Microbiome Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Human Microbiome Market Size Market Share by Country (2020-2025)
Table 34. Europe Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Human Microbiome Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Human Microbiome Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Human Microbiome Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Human Microbiome
Table 40. Key Market Challenges & Risks of Human Microbiome
Table 41. Key IndustryTrends of Human Microbiome
Table 42. Global Human Microbiome Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Human Microbiome Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Human Microbiome Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Human Microbiome Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Vedanta Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 47. Vedanta Human Microbiome Product Offered
Table 48. Vedanta Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Vedanta Main Business
Table 50. Vedanta Latest Developments
Table 51. SeresTherapeutics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 52. SeresTherapeutics Human Microbiome Product Offered
Table 53. SeresTherapeutics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. SeresTherapeutics Main Business
Table 55. SeresTherapeutics Latest Developments
Table 56. Second Genome Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 57. Second Genome Human Microbiome Product Offered
Table 58. Second Genome Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Second Genome Main Business
Table 60. Second Genome Latest Developments
Table 61. Rebiotix Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 62. Rebiotix Human Microbiome Product Offered
Table 63. Rebiotix Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Rebiotix Main Business
Table 65. Rebiotix Latest Developments
Table 66. ActoGeniX Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 67. ActoGeniX Human Microbiome Product Offered
Table 68. ActoGeniX Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. ActoGeniX Main Business
Table 70. ActoGeniX Latest Developments
Table 71. Enterome BioScience Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 72. Enterome BioScience Human Microbiome Product Offered
Table 73. Enterome BioScience Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Enterome BioScience Main Business
Table 75. Enterome BioScience Latest Developments
Table 76. AvidBiotics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 77. AvidBiotics Human Microbiome Product Offered
Table 78. AvidBiotics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. AvidBiotics Main Business
Table 80. AvidBiotics Latest Developments
Table 81. 4D Pharma Research Ltd Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 82. 4D Pharma Research Ltd Human Microbiome Product Offered
Table 83. 4D Pharma Research Ltd Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. 4D Pharma Research Ltd Main Business
Table 85. 4D Pharma Research Ltd Latest Developments
Table 86. Enterologics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 87. Enterologics Human Microbiome Product Offered
Table 88. Enterologics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Enterologics Main Business
Table 90. Enterologics Latest Developments
Table 91. Metabogen Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 92. Metabogen Human Microbiome Product Offered
Table 93. Metabogen Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Metabogen Main Business
Table 95. Metabogen Latest Developments
Table 96. Metabiomics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 97. Metabiomics Human Microbiome Product Offered
Table 98. Metabiomics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Metabiomics Main Business
Table 100. Metabiomics Latest Developments
Table 101. Ritter Pharmaceuticals Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 102. Ritter Pharmaceuticals Human Microbiome Product Offered
Table 103. Ritter Pharmaceuticals Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Ritter Pharmaceuticals Main Business
Table 105. Ritter Pharmaceuticals Latest Developments
Table 106. Osel Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 107. Osel Human Microbiome Product Offered
Table 108. Osel Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Osel Main Business
Table 110. Osel Latest Developments
Table 111. Symberix Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 112. Symberix Human Microbiome Product Offered
Table 113. Symberix Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Symberix Main Business
Table 115. Symberix Latest Developments
Table 116. Miomics Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 117. Miomics Human Microbiome Product Offered
Table 118. Miomics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Miomics Main Business
Table 120. Miomics Latest Developments
Table 121. Symbiotix Biotherapies Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 122. Symbiotix Biotherapies Human Microbiome Product Offered
Table 123. Symbiotix Biotherapies Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Symbiotix Biotherapies Main Business
Table 125. Symbiotix Biotherapies Latest Developments
Table 126. MicroBiomeTherapeutics LLC Details, CompanyType, Human Microbiome Area Served and Its Competitors
Table 127. MicroBiomeTherapeutics LLC Human Microbiome Product Offered
Table 128. MicroBiomeTherapeutics LLC Human Microbiome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. MicroBiomeTherapeutics LLC Main Business
Table 130. MicroBiomeTherapeutics LLC Latest Developments
LIST OFFIGURES
Figure 1. Human Microbiome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Microbiome Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Human Microbiome Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Human Microbiome Sales Market Share by Country/Region (2024)
Figure 8. Human Microbiome Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Human Microbiome Market Size Market Share byType in 2024
Figure 10. Human Microbiome inTreatment
Figure 11. Global Human Microbiome Market:Treatment (2020-2025) & ($ millions)
Figure 12. Human Microbiome in Diagnosis
Figure 13. Global Human Microbiome Market: Diagnosis (2020-2025) & ($ millions)
Figure 14. Global Human Microbiome Market Size Market Share by Application in 2024
Figure 15. Global Human Microbiome Revenue Market Share by Player in 2024
Figure 16. Global Human Microbiome Market Size Market Share by Region (2020-2025)
Figure 17. Americas Human Microbiome Market Size 2020-2025 ($ millions)
Figure 18. APAC Human Microbiome Market Size 2020-2025 ($ millions)
Figure 19. Europe Human Microbiome Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Human Microbiome Market Size 2020-2025 ($ millions)
Figure 21. Americas Human Microbiome Value Market Share by Country in 2024
Figure 22. United States Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Human Microbiome Market Size Market Share by Region in 2024
Figure 27. APAC Human Microbiome Market Size Market Share byType (2020-2025)
Figure 28. APAC Human Microbiome Market Size Market Share by Application (2020-2025)
Figure 29. China Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 33. India Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Human Microbiome Market Size Market Share by Country in 2024
Figure 36. Europe Human Microbiome Market Size Market Share byType (2020-2025)
Figure 37. Europe Human Microbiome Market Size Market Share by Application (2020-2025)
Figure 38. Germany Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 39.France Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Human Microbiome Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Human Microbiome Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Human Microbiome Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Human Microbiome Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Human Microbiome Market Size 2026-2031 ($ millions)
Figure 52. APAC Human Microbiome Market Size 2026-2031 ($ millions)
Figure 53. Europe Human Microbiome Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Human Microbiome Market Size 2026-2031 ($ millions)
Figure 55. United States Human Microbiome Market Size 2026-2031 ($ millions)
Figure 56. Canada Human Microbiome Market Size 2026-2031 ($ millions)
Figure 57. Mexico Human Microbiome Market Size 2026-2031 ($ millions)
Figure 58. Brazil Human Microbiome Market Size 2026-2031 ($ millions)
Figure 59. China Human Microbiome Market Size 2026-2031 ($ millions)
Figure 60. Japan Human Microbiome Market Size 2026-2031 ($ millions)
Figure 61. Korea Human Microbiome Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Human Microbiome Market Size 2026-2031 ($ millions)
Figure 63. India Human Microbiome Market Size 2026-2031 ($ millions)
Figure 64. Australia Human Microbiome Market Size 2026-2031 ($ millions)
Figure 65. Germany Human Microbiome Market Size 2026-2031 ($ millions)
Figure 66.France Human Microbiome Market Size 2026-2031 ($ millions)
Figure 67. UK Human Microbiome Market Size 2026-2031 ($ millions)
Figure 68. Italy Human Microbiome Market Size 2026-2031 ($ millions)
Figure 69. Russia Human Microbiome Market Size 2026-2031 ($ millions)
Figure 70. Egypt Human Microbiome Market Size 2026-2031 ($ millions)
Figure 71. South Africa Human Microbiome Market Size 2026-2031 ($ millions)
Figure 72. Israel Human Microbiome Market Size 2026-2031 ($ millions)
Figure 73.Turkey Human Microbiome Market Size 2026-2031 ($ millions)
Figure 74. Global Human Microbiome Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Human Microbiome Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Human Microbiome Market Size 2026-2031 ($ millions)
